Eva Morath

Title: Eva Morath: Innovator in Malaria Vaccine Development

Introduction

Eva Morath is a notable inventor based in Wuerzburg, Germany. She has made significant contributions to the field of medical research, particularly in the development of malaria vaccines. Her innovative work focuses on utilizing apicomplexan ferlins and related proteins to create effective vaccine solutions.

Latest Patents

Eva Morath holds a patent for her invention titled "Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other C2-domain containing proteins." This patent involves peptides that comprise at least one antigenic determinant or epitope of an apicomplexan Ferlin, Ferlin-like protein, and/or another C2-domain containing protein for use as malaria vaccines. The invention also includes compositions containing these peptides and their application as malaria vaccines.

Career Highlights

Throughout her career, Eva has worked at prestigious institutions, including Ruprecht-Karls-Universität Heidelberg. Her research has focused on the intersection of immunology and infectious diseases, contributing to advancements in vaccine development.

Collaborations

Eva Morath has collaborated with Ann-Kristin Mueller, who is also a prominent figure in the field of medical research. Their partnership has fostered innovative approaches to tackling malaria through vaccine research.

Conclusion

Eva Morath's work in malaria vaccine development exemplifies her commitment to advancing medical science. Her innovative patents and collaborations highlight her significant contributions to the field.